Osaic Holdings’s Co-Diagnostics CODX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18 Hold
10
﹤0.01% 7725
2025
Q4
$51 Sell
10
-55
-85% -$599 ﹤0.01% 7693
2025
Q3
$632 Hold
65
﹤0.01% 7486
2025
Q2
$542 Buy
65
+50
+333% +$468 ﹤0.01% 7335
2025
Q1
$143 Sell
15
-409
-96% -$7.82K ﹤0.01% 7204
2024
Q4
$9.54K Buy
424
+9
+2% +$284 ﹤0.01% 5835
2024
Q3
$15.6K Hold
415
﹤0.01% 5530
2024
Q2
$15.6K Buy
415
+23
+6% +$837 ﹤0.01% 5515
2024
Q1
$13.2K Buy
392
+350
+833% +$12.7K ﹤0.01% 5600
2023
Q4
$1.66K Sell
42
-30
-42% -$1.06K ﹤0.01% 6592
2023
Q3
$2.29K Buy
72
+16
+29% +$604 ﹤0.01% 6583
2023
Q2
$1.86K Sell
56
-98
-64% -$3.75K ﹤0.01% 6691
2023
Q1
$6.85K Sell
154
-71
-32% -$5.69K ﹤0.01% 6191
2022
Q4
$17K Sell
225
-18
-7% -$1.69K ﹤0.01% 5671
2022
Q3
$24K Sell
243
-31
-11% -$4.34K ﹤0.01% 5432
2022
Q2
$47K Hold
274
﹤0.01% 5005
2022
Q1
$54K Sell
274
-766
-74% -$159K ﹤0.01% 5034
2021
Q4
$278K Buy
1,040
+612
+143% +$161K ﹤0.01% 3646
2021
Q3
$124K Sell
428
-89
-17% -$26K ﹤0.01% 4329
2021
Q2
$129K Sell
517
-13
-2% -$3.34K ﹤0.01% 4255
2021
Q1
$152K Sell
530
-265
-33% -$106K ﹤0.01% 3994
2020
Q4
$222K Sell
795
-1,649
-67% -$611K ﹤0.01% 3385
2020
Q3
$1M Buy
2,444
+1,645
+206% +$845K ﹤0.01% 1829
2020
Q2
$463K Buy
799
+338
+73% +$154K ﹤0.01% 2411
2020
Q1
$108K Buy
+461
New +$79.9K ﹤0.01% 3407

Other funds holding CODX

Osaic Holdings's CODX Position: Q1 2026 in Review

Osaic Holdings held its Co-Diagnostics (CODX) position steady in Q1 2026 at 10 shares worth $18. The position accounts for ﹤0.01% of the portfolio, ranked #7725.

Osaic Holdings first reported a position in CODX in Q1 2020 and has held it in 25 quarters since. The position peaked at $1M in Q3 2020. 14 funds tracked by Wall St. Rank hold CODX as of Q1 2026.

  • Osaic Holdings held 10 shares of Co-Diagnostics worth $18 as of Q1 2026.
  • Osaic Holdings left its Co-Diagnostics share count unchanged in Q1 2026.
  • Co-Diagnostics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7725 holding.
  • Osaic Holdings first reported a position in Co-Diagnostics in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's Co-Diagnostics position peaked at $1M in Q3 2020.
  • 14 funds tracked by Wall St. Rank held Co-Diagnostics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.